Clinical Trial Update: Study of Bitopertin in Participants With EPP or XLP (APOLLO) [Phase 3]

View source ↗

Summary

Phase 3 trial ongoing evaluating bitopertin in participants with Erythropoietic Protoporphyria and X-Linked Protoporphyria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria
• X-linked Protoporphyria

Drugs mentioned

• Bitopertin (bitopertin)

Snippet

Sponsor: Disc Medicine, Inc | Conditions: Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP) | Phase 3 | Status: ACTIVE_NOT_RECRUITING